Deerfield Management Company, L.P. / NBIX
Deerfield Management Company, L.P.’s Neurocrine Biosciences Inc Position
Does Deerfield Management Company, L.P. own Neurocrine Biosciences Inc (NBIX)? Yes — 610.0K shares worth $80M (+0.95% of its 13F portfolio) as of Q1 2026, down from 1.18M shares the prior filed quarter.
Position Value
$80M
Q1 2026
Shares
610.0K
% of Portfolio
+0.95%
Quarters Held
21
currently held
Position History NBIX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 610.0K | $80M | +0.95% |
| Q4 2025 | 1.18M | $168M | +2.15% |
| Q3 2025 | 1.18M | $166M | +2.54% |
| Q2 2025 | 1.17M | $147M | +2.66% |
| Q1 2025 | 1.49M | $165M | +3.25% |
| Q4 2024 | 862.0K | $118M | +2.23% |
| Q3 2024 | 1.32M | $152M | +2.27% |
| Q2 2024 | 691.0K | $95M | +1.58% |
| Q1 2024 | 691.0K | $95M | +1.66% |
| Q4 2023 | 896.7K | $118M | +2.18% |
| Q3 2023 | 1.21M | $136M | +3.00% |
| Q2 2023 | 1.21M | $114M | +2.44% |
| Q1 2023 | 1.74M | $177M | +3.94% |
| Q4 2022 | 1.51M | $181M | +3.74% |
| Q3 2022 | 1.51M | $161M | +3.20% |
| Q2 2022 | 2.01M | $196M | +4.05% |
| Q1 2022 | 1.66M | $155M | +3.47% |
| Q4 2021 | 1.38M | $117M | +2.46% |
| Q3 2021 | 1.14M | $110M | +2.14% |
| Q2 2021 | 725.0K | $71M | +1.25% |
| Q1 2021 | 725.0K | $71M | +1.48% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deerfield Management Company, L.P.’s full portfolio or all institutional holders of NBIX.